BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruggeri M, Cicchetti A, Gasbarrini A. The cost-effectiveness of alternative strategies against HBV in Italy. Health Policy 2011;102:72-80. [DOI: 10.1016/j.healthpol.2010.09.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Myran DT, Morton R, Biggs BA, Veldhuijzen I, Castelli F, Tran A, Staub LP, Agbata E, Rahman P, Pareek M, Noori T, Pottie K. The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review. Int J Environ Res Public Health 2018;15:E1898. [PMID: 30200406 DOI: 10.3390/ijerph15091898] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
2 Nayagam S, Sicuri E, Lemoine M, Easterbrook P, Conteh L, Hallett TB, Thursz M. Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries. BMC Infect Dis 2017;17:692. [PMID: 29143675 DOI: 10.1186/s12879-017-2778-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
3 Rognoni C, Ciani O, Sommariva S, Tarricone R. Real-World Data for the Evaluation of Transarterial Radioembolization versus Sorafenib in Hepatocellular Carcinoma: A Cost-Effectiveness Analysis. Value Health 2017;20:336-44. [PMID: 28292478 DOI: 10.1016/j.jval.2016.09.2397] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
4 Ruggeri M, Manca A, Coretti S, Codella P, Iacopino V, Romano F, Mascia D, Orlando V, Cicchetti A. Investigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical Review. Value Health 2015;18:709-20. [PMID: 26297100 DOI: 10.1016/j.jval.2015.03.1795] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
5 Geue C, Wu O, Xin Y, Heggie R, Hutchinson S, Martin NK, Fenwick E, Goldberg D; Consortium., ECDC. Cost-Effectiveness of HBV and HCV Screening Strategies--A Systematic Review of Existing Modelling Techniques. PLoS One 2015;10:e0145022. [PMID: 26689908 DOI: 10.1371/journal.pone.0145022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
6 Lai Y, Li K, Li J, Liu SX. Cost-effectiveness of navigated radiofrequency ablation for hepatocellular carcinoma in China. Int J Technol Assess Health Care 2014;30:400-8. [PMID: 25682956 DOI: 10.1017/S0266462314000452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Hu Y, Cheng X, Cao F, Huang A, Tavis JE. β-Thujaplicinol inhibits hepatitis B virus replication by blocking the viral ribonuclease H activity. Antiviral Research 2013;99:221-9. [DOI: 10.1016/j.antiviral.2013.06.007] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 6.8] [Reference Citation Analysis]
8 Hahné SJ, Veldhuijzen IK, Wiessing L, Lim TA, Salminen M, Laar Mv. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening. BMC Infect Dis. 2013;13:181. [PMID: 23597411 DOI: 10.1186/1471-2334-13-181] [Cited by in Crossref: 142] [Cited by in F6Publishing: 144] [Article Influence: 15.8] [Reference Citation Analysis]
9 Cucchetti A, Piscaglia F, Cescon M, Colecchia A, Ercolani G, Bolondi L, Pinna AD. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol. 2013;59:300-307. [PMID: 23603669 DOI: 10.1016/j.jhep.2013.04.009] [Cited by in Crossref: 192] [Cited by in F6Publishing: 215] [Article Influence: 21.3] [Reference Citation Analysis]
10 Tavis JE, Cheng X, Hu Y, Totten M, Cao F, Michailidis E, Aurora R, Meyers MJ, Jacobsen EJ, Parniak MA, Sarafianos SG. The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes. PLoS Pathog 2013;9:e1003125. [PMID: 23349632 DOI: 10.1371/journal.ppat.1003125] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 8.8] [Reference Citation Analysis]